A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM)
Lawrence Kleinberg, Xiaobu Ye, Jeff Supko, Glen Stevens, Hui‐Kuo G. Shu, Tom Mikkelsen, Frank S. Lieberman, Glenn J. Lesser, Emerson Lee, Stuart A. Grossman
Topics & Concepts
VeliparibTemozolomideMedicinePARP inhibitorInternal medicinePharmacokineticsOncologyRadiation therapyPharmacologyPoly ADP ribose polymeraseChemistryGenePolymeraseBiochemistryPARP inhibition in cancer therapyGlioma Diagnosis and TreatmentBrain Metastases and Treatment